Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)
Authors
Keywords
Obesity, Diabetes mellitus, Nonalcoholic steatohepatitis, Liver diseases, Anticoagulant therapy, Atrial fibrillation, Fatty liver, Anticoagulants
Journal
PLoS One
Volume 16, Issue 9, Pages e0251665
Publisher
Public Library of Science (PLoS)
Online
2021-09-16
DOI
10.1371/journal.pone.0251665
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic fatty liver disease- evidence for a thrombophilic state?
- (2020) Margaret Spinosa et al. CURRENT PHARMACEUTICAL DESIGN
- Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review
- (2020) Stefano Ballestri et al. ADVANCES IN THERAPY
- Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication
- (2020) Diana M. Rydberg et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation
- (2020) Marina Serper et al. HEPATOLOGY
- The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index
- (2020) Hyo Eun Park et al. Scientific Reports
- Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
- (2020) Ashley Chen et al. Journal of the American Heart Association
- Direct oral anticoagulants and advanced liver disease: A systematic review and meta‐analysis
- (2020) Danilo Menichelli et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis
- (2019) Alessandro Mantovani et al. LIVER INTERNATIONAL
- The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting
- (2019) Gediminas Urbonas et al. Medicina-Lithuania
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation
- (2019) Sho-ichi Yamagishi Cardiovascular Diabetology
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- (2018) Alessandro Mantovani et al. DIABETES CARE
- Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data from a Large US Claims Database
- (2018) Alina M. Allen et al. HEPATOLOGY
- Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents
- (2018) Deborah K. Rose et al. Journal of Stroke & Cerebrovascular Diseases
- Oral Anticoagulation in Patients With Liver Disease
- (2018) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver
- (2018) Rohitash Jamwal et al. MOLECULAR PHARMACEUTICS
- Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents
- (2018) Deborah K. Rose et al. Journal of Stroke & Cerebrovascular Diseases
- Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis
- (2018) Jonathan G. Stine et al. Clinical and Translational Gastroenterology
- Changing Concepts of Cirrhotic Coagulopathy
- (2016) Armando Tripodi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Warfarin Dosing Algorithms and the Need for Human Intervention
- (2016) Scott E. Kasner et al. AMERICAN JOURNAL OF MEDICINE
- Mechanism of Drug-Drug Interactions Between Warfarin and Statins
- (2016) Abdul Naveed Shaik et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism
- (2016) Daniel M. Witt et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States
- (2016) William L. Baker et al. JOURNAL OF MANAGED CARE PHARMACY
- Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
- (2015) Amedeo Lonardo et al. DIGESTIVE AND LIVER DISEASE
- Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation
- (2015) Keitaro Senoo et al. STROKE
- Warfarin Dosing and Body Mass Index
- (2014) Julia A. Mueller et al. ANNALS OF PHARMACOTHERAPY
- Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease
- (2014) Lydia M. Efird et al.
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease
- (2014) Armando Tripodi et al. JOURNAL OF HEPATOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011
- (2012) Kate Kirley et al.
- Comparison of initial warfarin response in obese patients versus non-obese patients
- (2012) Jessica L. Wallace et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples
- (2011) Jeremy A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Hypercoagulability in cirrhosis: causes and consequences1
- (2011) A. TRIPODI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Coagulopathy of Chronic Liver Disease
- (2011) Armando Tripodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
- (2010) A. J. ROSE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism
- (2010) Matteo Nicola Dario Di Minno WORLD JOURNAL OF GASTROENTEROLOGY
- Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
- (2009) L. Serfaty et al. DIABETES & METABOLISM
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
- (2008) Christopher Ll. Morgan et al. THROMBOSIS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started